Thermo Fisher Scientific Inc. with ticker code (TMO) now have 24 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $670.00 and $553.00 with the average target price sitting at $624.17. Now with the previous closing price of $599.02 and the analysts are correct then we can expect a percentage increase in value of 4.2%. It’s also worth noting that there is a 50 day moving average of $577.05 and the 200 day moving average is $532.36. The company has a market capitalization of 227.94B. The stock price for the company is currently $597.15 USD
The potential market cap would be $237,511,899,935 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 38.3, revenue per share of $110.37 and a 4.82% return on assets.
Thermo Fisher Scientific Inc. is engaged in serving science. The Company operates through four segments. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. Analytical Instruments segment provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and food safety laboratories. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. Its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
